Skip to content
PubMed This is a summary of 7 peer-reviewed journal articles Updated
Neurology

What Is Late-Onset Friedreich Ataxia (LOFA) in Adults?

At a Glance

Late-onset Friedreich ataxia (LOFA) is an inherited form of Friedreich ataxia in which balance or coordination symptoms first appear at ages 25–39; very late-onset FA begins at 40 or older. Genetic testing confirms the diagnosis, but progression and complications vary.

Yes, while Friedreich ataxia (FA) is most often diagnosed in childhood or early adolescence, it is entirely possible to first develop symptoms as an adult. This is known as late-onset Friedreich ataxia (LOFA) or very late-onset Friedreich ataxia (VLOFA), depending on your exact age when symptoms begin [1]. You do not “catch” the disease as an adult; rather, the underlying genetic cause was present from birth, but it took longer for the neurological symptoms to appear.

Defining LOFA and VLOFA

Doctors often use specific categories based on the age when symptoms—such as balance issues or clumsiness—first become noticeable, though identifying the exact start of subtle symptoms can be difficult. These are commonly used research categories, and cutoffs can vary:

  • Late-onset Friedreich ataxia (LOFA): Symptoms first appear between the ages of 25 and 39 [1][2].
  • Very late-onset Friedreich ataxia (VLOFA): Symptoms first appear at age 40 or older [1].

Adult-onset balance or coordination problems have many possible causes. Diagnosis requires a thorough neurologic evaluation and genetic testing to confirm the presence of disease-causing mutations in both copies of the FXN gene [2].

The Genetic Connection

FA is an autosomal recessive condition caused by an extra-long repeated DNA sequence, known as a GAA repeat expansion, in the FXN gene. This expansion limits the body’s ability to produce a vital protein called frataxin [3]. Because it is a recessive condition, people with FA inherit one mutated gene copy from each parent; those parents are typically healthy carriers, meaning a family history of the disease is often absent.

Most people with FA have GAA expansions in both of their FXN gene copies (alleles), though a small number have one expansion and a different type of mutation in the other copy [3].

People who develop FA in adulthood typically have shorter GAA repeat lengths—specifically, a shorter expansion on the smaller of their two FXN alleles [1][4]. A shorter repeat is associated with the body producing slightly more frataxin protein, which is associated with later symptom onset [1][3]. However, repeat lengths are not a crystal ball: they show an average tendency but cannot predict your exact individual progression, cardiac risk, or when you might need mobility assistance.

How Adult-Onset FA is Different

Because of the delayed onset and shorter genetic repeats, LOFA and VLOFA often look different from classic childhood FA. This can sometimes cause diagnostic confusion, as adult-onset symptoms can resemble other causes of ataxia, neuropathy, or spasticity [5].

  • Slower Average Progression: On average, adult-onset FA progresses more slowly than childhood-onset FA. People with LOFA or VLOFA typically experience a longer period of time between their first symptoms and choosing to use mobility aids for safety and independence [1][6]. However, progression varies widely, and some adults still experience substantial mobility changes.
  • Fewer Non-Neurological Symptoms (But Screening is Still Vital): The complications that affect the rest of the body are usually less frequent in adults. For example, in one Brazilian cohort study, scoliosis (curvature of the spine) affected only 22% of people with LOFA compared to 61% of those with classic FA [5]. Cardiomyopathy (disease of the heart muscle) and diabetes are also seen less frequently in late-onset cases [1][5]. Importantly, lower risk does not mean no risk. Cardiac disease in FA can be silent, and you still need ongoing, guideline-based cardiac, glucose, and orthopedic assessments customized by your care team [7].
  • Different Neurological Signs: In classic childhood FA, tapping the knee with a reflex hammer usually gets no response (absent reflexes). In contrast, adults with LOFA may have preserved or brisk reflexes (hyperreflexia), and some may experience spasticity (increased muscle tone and stiffness) [1][5]. Additionally, speech difficulties (dysarthria) may be less prominent or appear much later in the disease course [2][5].

Receiving a later-than-usual diagnosis can be confusing, but understanding how LOFA differs from classic FA helps your care team tailor your symptom management. A genetic counselor can also help you understand what your diagnosis means for your siblings, partner, or other relatives.

Common questions in this guide

What age ranges define LOFA and VLOFA?
LOFA usually refers to Friedreich ataxia symptoms that begin between ages 25 and 39. VLOFA refers to symptoms beginning at age 40 or older. These are commonly used research categories, and exact age cutoffs can vary.
Why would Friedreich ataxia symptoms appear for the first time in adulthood?
Friedreich ataxia is caused by an inherited change in both copies of the FXN gene, so the genetic cause is present from birth. Adults with later-onset disease often have shorter GAA expansions on the smaller FXN copy, which is associated with producing slightly more frataxin and delaying symptoms. This association does not predict exactly how the condition will progress.
How is late-onset Friedreich ataxia diagnosed?
Adult balance or coordination problems can have many causes, so diagnosis starts with a thorough neurologic evaluation. Genetic testing looks for disease-causing variants in both copies of the FXN gene, including GAA repeat expansions and, in some people, another type of mutation.
Does LOFA usually progress more slowly than childhood-onset Friedreich ataxia?
On average, LOFA and VLOFA progress more slowly than childhood-onset disease, and adults often have a longer interval before using mobility aids. Progression varies widely, however, and some people still develop substantial changes in walking or other mobility.
Can late-onset Friedreich ataxia affect the heart or cause diabetes?
Heart muscle disease, diabetes, and scoliosis are generally less common in late-onset FA than in classic childhood-onset FA, but they can still occur. Heart disease may be silent, so your care team should set a personalized schedule for cardiac, glucose, and orthopedic assessments.
Should my family members or partner have genetic counseling?
A genetic counselor can explain what an autosomal recessive diagnosis means for siblings, a partner, and other relatives. Because parents are often healthy carriers and family history may be absent, relatives may not realize that an FXN variant is present; whether testing is appropriate depends on the person's relationship and reproductive or health concerns.
What can my GAA repeat lengths tell me about LOFA?
Shorter GAA repeat lengths, particularly on the smaller FXN allele, are associated on average with later symptom onset and slightly more frataxin production. They cannot predict an individual's exact progression, heart risk, or when mobility support will be needed.

Get notified when new evidence is published on Friedreich ataxia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (7)
  1. 1

    Delayed-onset Friedreich's ataxia revisited.

    Lecocq C, Charles P, Azulay JP, et al.

    Movement disorders : official journal of the Movement Disorder Society 2016; (31(1)):62-9 doi:10.1002/mds.26382.

    PMID: 26388117
  2. 2

    Very-late-onset Friedreich's ataxia: diagnosis in a kindred with late-onset cerebellar ataxia.

    Fearon C, Lonergan R, Ferguson D, et al.

    Practical neurology 2020; (20(1)):55-58 doi:10.1136/practneurol-2019-002368.

    PMID: 31467149
  3. 3

    Clinical Evidence for Variegated Silencing in Patients With Friedreich Ataxia.

    Rodden LN, Rummey C, Dong YN, Lynch DR

    Neurology. Genetics 2022; (8(3)):e683 doi:10.1212/NXG.0000000000000683.

    PMID: 35620135
  4. 4

    Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data.

    Reetz K, Dogan I, Costa AS, et al.

    The Lancet. Neurology 2015; (14(2)):174-82.

    PMID: 25566998
  5. 5

    Nonneurological Involvement in Late-Onset Friedreich Ataxia (LOFA): Exploring the Phenotypes.

    Martinez AR, Moro A, Abrahao A, et al.

    Cerebellum (London, England) 2017; (16(1)):253-256 doi:10.1007/s12311-015-0755-8.

    PMID: 26754264
  6. 6

    Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 4-year cohort study.

    Reetz K, Dogan I, Hilgers RD, et al.

    The Lancet. Neurology 2021; (20(5)):362-372 doi:10.1016/S1474-4422(21)00027-2.

    PMID: 33770527
  7. 7

    Nonataxia symptoms in Friedreich Ataxia: Report from the Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS).

    Reetz K, Dogan I, Hohenfeld C, et al.

    Neurology 2018; (91(10)):e917-e930 doi:10.1212/WNL.0000000000006121.

    PMID: 30097477

This page is for informational purposes only and does not constitute medical advice. A neurologist and genetic counselor can help interpret your genetic results and tailor cardiac, glucose, orthopedic, and symptom monitoring to your needs.